Drug Pricing Evolution in Hepatitis C

• Nathalie Vernaz ,

  * E-mail: nathalie.vernaz@hcuge.ch

  Affiliations Medical Direction, Geneva University Hospitals, University of Geneva, Geneva, Switzerland, Finance Direction, Geneva University Hospitals, Geneva, Switzerland

  ⨯
• François Girardin,

  Affiliations Medical Direction, Geneva University Hospitals, University of Geneva, Geneva, Switzerland, Division of Clinical Pharmacology and Toxicology, Geneva University Hospitals, University of Geneva, Geneva, Switzerland

  ⨯
• Nicolas Goossens,

  Affiliation Divisions of Gastroenterology and Hepatology, Geneva University Hospitals, University of Geneva, Geneva, Switzerland

  ⨯
• Urs Brügger,

  Affiliation Winterthur Institute of Health Economics, Zurich University of Applied Sciences, Winterthur, Switzerland

  ⨯
• Marco Riguzzi,

  Affiliation Winterthur Institute of Health Economics, Zurich University of Applied Sciences, Winterthur, Switzerland

  ⨯
• Arnaud Perrier,

  Affiliations Medical Direction, Geneva University Hospitals, University of Geneva, Geneva, Switzerland, Division of General Internal Medicine, Geneva University Hospitals, University of Geneva, Geneva, Switzerland

  ⨯
• Francesco Negro

  Affiliation Divisions of Gastroenterology and Hepatology and of Clinical Pathology, Geneva University Hospitals, Geneva, Switzerland

  ⨯